Form 8-K · Current report
News Corp 8-K, filed Aug 26, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000188
Summary
News Corp repurchased 54,641 Class A common shares on August 25, 2026 for total consideration of about US$1.68 million, disclosed in its daily buy-back notification to the Australian Securities Exchange under its 2025 Repurchase Program for up to US$1 billion of Class A and Class B stock.
Key points
- News Corp is authorized to acquire up to US$1 billion in aggregate of its Nasdaq-listed Class A and Class B common stock under the 2025 Repurchase Program, authorized as of July 15, 2025.
- Prices paid on August 25, 2026 ranged from US$30.24 to US$31.01 per share.
- To date the company has bought back 11,189,201 shares for about US$288.1 million, and approximately US$443.8 million in total has been spent under the program.
- No shareholder approval is required and the company states the reason for the buy-back is to enhance shareholder value.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.